HUMAN NORMAL IMMUNOGLOBULIN (IV), Placebo for empasiprubart- solution for IV infusion, Placebo for IVIg - solution for IV infusion, ARGX-117
ARGX-117-2401
Phase 3 small_molecule active
Quick answer
HUMAN NORMAL IMMUNOGLOBULIN (IV), Placebo for empasiprubart- solution for IV infusion, Placebo for IVIg - solution for IV infusion, ARGX-117 for Chronic inflammatory demyelinating polyneuropathy (CIDP) is a Phase 3 program (small_molecule) at Argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Argenx
- Indication
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active